No results for ‘’
TTK Healthcare Ltd
₹1115.40
(1.67%)
Wed, 16 Sept 2026, 04:24 pm
Health Technology
Pharmaceuticals: Major
24.5KTTK Healthcare Enterprise Value (EV)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 28.98 | 20.38 | 4.72 | 9.81 | 21.95 | 21.30 | 19.42 | 22.10 | 32.82 | 44.71 | 31.69 | 32.85 | 81.83 | 39.34 | 37.50 | 15.05 | 28.17 | 2.28 | 33.35 | 20.71 |
| Price to book ratio | 1.59 | 1.38 | 1 | 1.24 | 3.08 | 4.16 | 3.46 | 3.20 | 3.80 | 6.11 | 5.27 | 3.91 | 6.38 | 3.81 | 1.86 | 2.37 | 3.55 | 1.53 | 2.09 | 1.59 |
| Price to sales ratio | 0.31 | 0.29 | 0.29 | 0.35 | 0.79 | 1.01 | 0.86 | 0.82 | 0.98 | 1.50 | 1.40 | 1.17 | 2.57 | 1.53 | 0.72 | 1.47 | 1.96 | 2.01 | 2.78 | 2.11 |
| Price to cash flow ratio | 6.90 | 123.62 | 8.76 | 6.93 | 11.58 | 13.23 | 78.69 | 14.31 | 41.38 | 20.09 | 21.04 | 31.99 | 53.17 | 44.81 | 18.57 | 6.23 | 21.34 | 0 | 42.26 | 29.32 |
| Enterprise value | 56.95Cr | 48.94Cr | 20.96Cr | 42.15Cr | 165Cr | 265Cr | 253Cr | 252Cr | 354Cr | 686Cr | 670Cr | 556Cr | 1397Cr | 862Cr | 360Cr | 490Cr | 920Cr | 641Cr | 1273Cr | 860Cr |
| Enterprise value to EBITDA ratio | 8.55 | 7.14 | 3.69 | 3.73 | 10.52 | 12.31 | 10.53 | 12.31 | 18.24 | 23.12 | 18.38 | 14.24 | 32.66 | 16.92 | 12.21 | 24.44 | 40.15 | 19.86 | 32.90 | 23.89 |
| Debt to equity ratio | 0.37 | 0.29 | 0.23 | 0.24 | 0.22 | 0.16 | 0.21 | 0.23 | 0.29 | 0.35 | 0.28 | 0.15 | 0.20 | 0.11 | 0.12 | 0.06 | 0.07 | 0.03 | 0.02 | 0.02 |
| Return on equity % | 0 | 7.10 | 23.14 | 13.19 | 14.40 | 21.02 | 19.16 | 15.28 | 12.08 | 14.35 | 17.81 | 12.76 | 9.47 | 10.06 | 4.92 | 13.53 | 5.93 | 6.96 | 6.43 | 7.90 |
TTK Healthcare Ltd Enterprise Value
The TTK Healthcare Ltd Enterprise Value is a key financial metric used by investors to evaluate TTK Healthcare Ltd's valuation, profitability, and overall financial performance. Tracking the TTK Healthcare Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
TTK Healthcare Ltd (NSE: TTKHLTCARE, BSE: 507747) is currently trading at ₹1115.40, with a market capitalization of ₹1577.02Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the TTK Healthcare Ltd Enterprise Value is essential for fundamental analysis.
TTK Healthcare Ltd Enterprise Value Current Value
The current TTK Healthcare Ltd Enterprise Value stands at 860Cr.
The TTK Healthcare Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
TTK Healthcare Ltd Enterprise Value Historical Trend
The TTK Healthcare Ltd Enterprise Value has shown the following historical trend:
- 2024: 860Cr
- 2023: 1273Cr
- 2022: 641Cr
- 2021: 920Cr
- 2020: 490Cr
The decline in TTK Healthcare Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What TTK Healthcare Ltd Enterprise Value Indicates for Investors
The TTK Healthcare Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of TTK Healthcare Ltd.
TTK Healthcare Ltd Enterprise Value Analysis Summary
The TTK Healthcare Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking TTK Healthcare Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of TTK Healthcare Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.